Inoviq Ltd Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Peter Gunzburg, was filed 25 May 2026.
Inoviq Ltd: what insiders have been doing
Inoviq Ltd belongs to the Health Care sector. Filings by its managers are published through ASX. The last twelve months, up to 2 November 2026, brought 5 filings signed by 3 insiders.
On the market, 1 insider bought (2 purchases totalling €8,378) while 1 insider sold (1 sale). The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. On the buying side, the filings list 1 senior executive among the declarants. One trade stands out by size: a purchase of €5,821 from Peter Gunzburg, disclosed on 25 May 2026.
The last insider purchase was made public on 25 May 2026, 166 days ago.
Compared with its exchange (1,612 companies, median 5 filings), a count of 5 filings is typical. Our records for Inoviq Ltd go back to 2026, with 2 purchases and 1 sale on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Source: insider filings from ASX. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -58.5%Entry A$0.32 · Close 29 Oct 2026 A$0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXISIN AU0000196149ASX:2924-03157044-3A705641
- ShareASXASX:2924-03118769-3A698351
- 315,000 sharesShareASXISIN AU0000196149ASX:2924-03111346-3A697218
- ▲Executives9,450 AUD0ASX
- 13,000 shares@ A$0.32100.0% of flowShareASXASX:2924-03092673-3A693800Canonical exit: 19 Aug 2026 (T+90)
5 of 5 declarations
About Inoviq Ltd
Inoviq Ltd is a company listed on the XASX, specializing in the development of diagnostic solutions for cancer. It focuses on improving patient outcomes through innovative technologies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
